T3	Effect 26 42	HBV reactivation
T5	Treatment 60 153	the year following rituximab monotherapy in the absence of any other immunosuppressive factor
T6	Drug 79 88	rituximab
T7	Time_elapsed 64 78	year following
T4	Adverse_event 43 52	occurring
E1	Adverse_event:T4